[Cranial neuropathy and cancer].
Dalmau
J
J
Graus
F
F
D000970:Antineoplastic Agents / Q000009:adverse effects; D001932:Brain Neoplasms / Q000150:complications / Q000556:secondary; D001933:Brain Stem; D002680:Chin / Q000294:innervation; D003389:Cranial Nerve Diseases / Q000139:chemically induced / Q000209:etiology*; D003390:Cranial Nerve Neoplasms / Q000150:complications / Q000556:secondary; D005154:Facial Nerve; D006258:Head and Neck Neoplasms / Q000601:surgery; D006801:Humans; D008577:Meningeal Neoplasms / Q000150:complications / Q000556:secondary; D009181:Mycoses / Q000150:complications; D009897:Optic Chiasm; D010257:Paraneoplastic Syndromes / Q000150:complications; D010911:Pituitary Neoplasms / Q000150:complications / Q000556:secondary; D011183:Postoperative Complications / Q000209:etiology; D011832:Radiation Injuries / Q000150:complications; D012888:Skull Neoplasms / Q000150:complications / Q000556:secondary; D014777:Virus Diseases / Q000150:complications
D000970:Antineoplastic Agents
Neuropatía craneal y cáncer.